|

Have the weight-loss drugs you’re hearing about in the media been thoroughly vetted for safety?

With the booming popularity of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro for weight loss, we must examine the legal and medical implications tied to their usage. As law firms handle more and more cases involving pharmaceutical companies, understanding the underpinning legalities becomes imperative.

Today’s guest is Marcus Susen, an accomplished Civil Trial Attorney and Founder of Susen Law Group. Known for his pivotal role in the legal battles surrounding weight loss drugs, Marcus is here to shed light on the growing litigation.

Marcus is part of the leadership steering committee for the consolidated Ozempic lawsuits and was handpicked by the judge from over a thousand candidates. Clearly, Marcus brings unparalleled expertise to this pressing topic.

In this episode of Cut to the Chase: Podcast, you’ll hear crucial insights into the current status and future trajectory of these weight loss drug litigations. You’ll also learn the little-known side effects of GLP-1 drugs that are impacting so many lives around the country.

What to expect in this episode:

  • The current legal landscape surrounding Ozempic and other GLP-1 drugs

  • FDA approvals and the evolving market for weight loss medications

  • Failures in patient and doctor warnings: A deep dive into emerging health risks (blindness, gastroparesis, & more)

  • The crucial early litigious steps: Filing cases, discovery, and diagnostic tests

  • Understanding “Science Day”: How scientific evidence is presented in court

  • Marcus’s take on future outcomes and potential growth in case numbers regarding GLP-1 drugs

Key Actionable Takeaways for Law Firms:

  • Stay Informed: Regularly update your knowledge base on FDA drug safety announcements and emerging studies.

  • Client Communication: Educate clients about potential risks associated with widely-used medications and ensure they’re fully informed.

  • Data Management: Prepare for extensive discovery phases involving vast amounts of medical records.

  • Specialization: Consider co-counseling with niche experts to leverage specialized knowledge in pharmaceutical litigations.

  • Expand Awareness: Advocate for proper labeling and risk disclosure from pharmaceutical companies to protect patient rights.

 

Stay tuned for more updates, and don’t miss our next deep dive on Cut to The Chase: Podcast with Gregg Goldfarb!

Subscribe, rate, review, and share this episode of the Cut to the Chase: Podcast to stay ahead in your legal practice!

 

Resources:

Connect with Marcus Susen at Susen Law Group: https://susenlawgroup.com

 

This episode was produced and brought to you by Reignite Media.